The Nifty Pharma index closed on a negative note on Tuesday. Shares of Ajanta Pharma Ltd.(up 3.6 per cent), Abbott India Ltd.

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the European Commission (EC) granted marketing authorisation in the ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

AM(IST)on Tuesday in a weak market. Abbott India Ltd.(up 0.47 per cent) and Glenmark Pharmaceuticals Ltd.(up 0.44 per cent) ...

For investors eyeing Biocon’s stock, this approval could be a significant catalyst. According to InvestingPro’s fair value ...

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

Defence Minister Rajnath Singh projected Bengaluru as the epicentre of India’s technological future, asserting that the city ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, and ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...